Biosimilars: breaking down barriers of prejudice
The use of trastuzumab and biosimilars in the treatment of breast cancer
COMy 2017: Day 1 discussion on progress in multiple myeloma, patient advocacy and drug costs
Arnon Nagler et al.
Are biosimilars similar enough?
How to address the issue of access to new drugs in multiple myeloma
Paul Richardson et al.